Addy M, Moran J M
Division of Restorative Dentistry, Dental School, Bristol, United Kingdom.
Periodontol 2000. 1997 Oct;15:40-51. doi: 10.1111/j.1600-0757.1997.tb00103.x.
Most people in industrialized countries use oral hygiene products. When an oral health benefit is expected, it is important that sufficient scientific evidence exist to support such claims. Ideally, data should be cumulative derived from studies in vitro and in vivo. The data should be available to the profession for evaluation by publication in refereed scientific journals. Terms and phrases require clarification, and claims made by implication or derived by inference must be avoided. Similarity in products is not necessarily proof per se of efficacy. Studies in vitro and in vivo should follow the basic principles of scientific research. Studies must be ethical, avoid bias and be suitably controlled. A choice of controls will vary depending on whether an agent or a whole product is evaluated and the development stage of a formulation. Where appropriate, new products should be compared with products already available and used by the general public. Conformity with the guidelines for good clinical practice appears to be a useful way of validating studies and a valuable guide to the profession. Studies should be designed with sufficient power to detect statistically significant differences if these exist. However, consideration must be given to the clinical significance of statistically significant differences between formulations since these are not necessarily the same. Studies in vitro provide supportive data but extrapolation to clinical effect is difficult and even misleading, and such data should not stand alone as proof of efficacy of a product. Short-term studies in vivo provide useful information, particularly at the development stage. Ideally, however, products should be proved effective when used in the circumstances for which they are developed. Nevertheless, a variety of variable influence the outcome of home-use studies, and the influence of the variable cannot usually be calculated. Although rarely considered, the cost-benefit ratio of some oral hygiene products needs to be considered.
工业化国家的大多数人都使用口腔卫生产品。当期望获得口腔健康益处时,重要的是要有足够的科学证据来支持此类宣称。理想情况下,数据应是从体外和体内研究中累积得出的。这些数据应通过在经同行评审的科学期刊上发表,供专业人士评估。术语和短语需要加以澄清,必须避免隐含或推断得出的宣称。产品的相似性本身不一定能证明其有效性。体外和体内研究应遵循科学研究的基本原则。研究必须符合伦理道德,避免偏差并进行适当的对照。对照的选择将取决于评估的是一种成分还是整个产品,以及配方的开发阶段。在适当的情况下,新产品应与公众已经使用的现有产品进行比较。符合良好临床实践指南似乎是验证研究的一种有用方式,也是给专业人士的宝贵指导。研究设计应有足够的效力,以便在存在统计学显著差异时能够检测到。然而,必须考虑配方之间统计学显著差异的临床意义,因为两者不一定相同。体外研究提供支持性数据,但外推至临床效果很困难,甚至会产生误导,此类数据不应单独作为产品有效性的证据。体内短期研究提供有用信息,尤其是在开发阶段。然而,理想情况下,产品应在其开发所针对的使用环境中被证明是有效的。尽管如此,多种变量会影响家庭使用研究的结果,而且通常无法计算这些变量的影响。虽然很少被考虑,但一些口腔卫生产品的成本效益比也需要加以考虑。